喵ID:CrZq54免责声明

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

HIV 控制者及其家庭成员中 ccr5 转录下调

基本信息

DOI:
--
发表时间:
2019
期刊:
影响因子:
7.7
通讯作者:
Richard E Sutton
中科院分区:
生物学1区
文献类型:
--
作者: E. Gonzalo;Patrick B Rapuano;Uchenna T Ikediobi;Rebecca Leibowitz;S. Mehta;Ayse K Coskun;J Zachary Porterfield;Teagan D Lampkin;Vincent C. Marconi;D. Rimland;Bruce D Walker;S. Deeks;Richard E Sutton研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

HIV +Elite and Viremic controllers (EC/VCs) are able to control virus infection, perhaps because of host genetic determinants. We identified 16% (21 of 131) EC/VCs with CD4 +T cells with resistance specific to R5-tropic HIV, reversed after introduction of ccr5. R5 resistance was not observed in macrophages and depended upon the method of T cell activation. CD4 +T cells of these EC/VCs had lower ccr2 and ccr5 RNA levels, reduced CCR2 and CCR5 cell-surface expression, and decreased levels of secreted chemokines. T cells had no changes in chemokine receptor mRNA half-life but instead had lower levels of active transcription of ccr2 and ccr5, despite having more accessible chromatin by ATAC-seq. Other nearby genes were also down-regulated, over a region of ~500 kb on chromosome 3p21. This same R5 resistance phenotype was observed in family members of an index VC, also associated with ccr2/ccr5 down-regulation, suggesting that the phenotype is heritable.
HIV +精英控制者和病毒血症控制者(EC/VCs)能够控制病毒感染,这可能是由于宿主的遗传决定因素。我们发现16%(131例中有21例)的EC/VCs的CD4 +T细胞对R5嗜性HIV具有特异性抗性,在引入ccr5后这种抗性逆转。在巨噬细胞中未观察到R5抗性,且该抗性取决于T细胞的激活方法。这些EC/VCs的CD4 +T细胞具有较低的ccr2和ccr5 RNA水平,CCR2和CCR5细胞表面表达降低,分泌的趋化因子水平下降。T细胞的趋化因子受体mRNA半衰期没有变化,但ccr2和ccr5的活性转录水平较低,尽管通过ATAC - seq检测到染色质可及性更高。其他附近的基因在3p21号染色体上约500 kb的区域内也被下调。在一名索引VC的家庭成员中也观察到了相同的R5抗性表型,且也与ccr2/ccr5下调有关,这表明该表型是可遗传的。
参考文献(8)
被引文献(13)
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
DOI:
10.1172/jci44539
发表时间:
2011-04-01
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
Chen, Huabiao;Li, Chun;Lichterfeld, Mathias
通讯作者:
Lichterfeld, Mathias
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
DOI:
10.1086/653677
发表时间:
2010-07-15
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
0
作者:
Julg B;Pereyra F;Buzón MJ;Piechocka-Trocha A;Clark MJ;Baker BM;Lian J;Miura T;Martinez-Picado J;Addo MM;Walker BD
通讯作者:
Walker BD
Late onset ST-elevation myocardial infarction (STEMI) in patient with COVID-19: A case report from Nepal.
DOI:
10.1016/j.amsu.2022.103764
发表时间:
2022-06
期刊:
ANNALS OF MEDICINE AND SURGERY
影响因子:
1.7
作者:
Mandal, Prince;Shah, Sangam;Chamlagain, Rajan;Rawal, Laba;Gami, Roshan;Kartikey, Abeer;Singh, Aanand Kumar;Sah, Sanjit Kumar;Joshi, Amir;Acharya, Sudarshan
通讯作者:
Acharya, Sudarshan
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.
DOI:
10.1016/j.immuni.2014.01.006
发表时间:
2014-02-20
期刊:
IMMUNITY
影响因子:
32.4
作者:
Xue, Jia;Schmidt, Susanne V.;Sander, Jil;Draffehn, Astrid;Krebs, Wolfgang;Quester, Inga;De Nardo, Dominic;Gohel, Trupti D.;Emde, Martina;Schmidleithner, Lisa;Ganesan, Hariharasudan;Nino-Castro, Andrea;Mallmann, Michael R.;Labzin, Larisa;Theis, Heidi;Kraut, Michael;Beyer, Marc;Latz, Eicke;Freeman, Tom C.;Ulas, Thomas;Schultze, Joachim L.
通讯作者:
Schultze, Joachim L.
Phosphorylation and functions of the RNA polymerase IICTD
DOI:
10.1101/gad.1477006
发表时间:
2006-11-01
期刊:
GENES & DEVELOPMENT
影响因子:
10.5
作者:
Phatnani, Hemali P.;Greenleaf, Arno L.
通讯作者:
Greenleaf, Arno L.

数据更新时间:{{ references.updateTime }}

Richard E Sutton
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓